Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medical College of Wisconsin
With
University of Illinois at Chicago
Age
18–100
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Adult (≥ 18 years) assigned female sex at birth
Diagnosed with invasive non-metastatic breast cancer
Receiving neo-adjuvant CTx (or adjuvant CTx and undergoing breast conserving surgery) that includes anthracyclines (such as DOX) and/or targeted anti-Her2 therapy
Able to safely participate in moderate exercise and strength training based on MD approval
Willing to complete all study activities
Self-identifies as Black/African American or non-Hispanic White
You may not be if
Unintentional weight loss \> 10% in the past 6 months
Current pregnant and lactating patients. Must have completed lactation prior to study start
Metastatic disease
Diagnosed cardiovascular disease as evidenced by cardiomyopathy (reduced regional or global LV contractility), diastolic dysfunction grade 2 or above, symptomatic coronary - artery disease, ejection fraction below 50%
History of prior chemotherapy or targeted H2N Treatment received less than 3 years ago
Non-English speaking
Clareo Health | Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction
